Skip to content

It looks like we may have content for your preferred language. Would you like to view this page in English?

Helsinn, Roche Sue Over Planned Generic Of Nausea Drug

Loeb & Loeb partner Mark Waddell is named as counsel for Roche Palo Alto LLC in connection with a patent suit that the Roche and drugmaker Helsinn Healthcare SA filed suit against two generic makers over their application for U.S. Food and Drug Administration approval of a version of the anti-nausea medication, Aloxi. 

Click here to read the article on the Law360 website.